Anticoagulants/antiplateletsBleeding events: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1830卷 / 1期

关键词：

D O I：

10.1007/s40278-020-85989-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：39 / 39

相关论文

共 50 条

[31] Anticoagulants/bevacizumabIntraparenchymal haemorrhage: 4 case reports
[J]. Reactions Weekly, 2017, 1653 (1) : 45 - 45
[32] Anticoagulants/aspirin/clopidogrelBleeding: 7 case reports
[J]. Reactions Weekly, 2021, 1843 (1) : 36 - 36
[33] Antiplatelet/anticoagulants overdoseBleeding: 16 case reports
[J]. Reactions Weekly, 2018, 1694 (1) : 46 - 46
[34] Anticoagulants/antiplateletsVarious toxicities: 8 case reports
[J]. Reactions Weekly, 2020, 1835 (1) : 29 - 29
[35] Anticoagulants/antiplateletsIntracranial haemorrhages: 5 case reports
[J]. Reactions Weekly, 2018, 1687 (1) : 33 - 33
[36] Aspirin/clopidogrel/tirofibanBleeding events and decrease in haemoglobin: 6 case reports
[J]. Reactions Weekly, 2021, 1867 (1) : 65 - 65
[37] PembrolizumabVarious immune therapy related adverse events: 6 case reports
[J]. Reactions Weekly, 2019, 1779 (1) : 187 - 187
[38] Anticoagulants/antiplateletsDelayed intracranial haemorrhage: 3 case reports
[J]. Reactions Weekly, 2020, 1824 (1) : 32 - 32
[39] Anticoagulants/amiodarone/aspirinIntracranial haemorrhage: 3 case reports
[J]. Reactions Weekly, 2016, 1616 (1) : 23 - 23
[40] Anticoagulants/antihypertensivesCholesterol crystal embolisms: 10 case reports
[J]. Reactions Weekly, 2018, 1703 (1) : 35 - 35

← 1 2 3 4 5 →